Filing Details

Accession Number:
0000950170-24-098047
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-08-16 16:05:05
Reporting Period:
2024-08-15
Accepted Time:
2024-08-16 16:05:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
31791 Revvity Inc. RVTY Laboratory Analytical Instruments (3826) 042052042
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1044005 P Alexis Michas 940 Winter Street
Waltham MA 02451
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-08-15 850 $118.62 7,770 No 4 S Indirect By The Cayre and Alexis Michas Foundation Corp.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By The Cayre and Alexis Michas Foundation Corp.
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 58,203 Direct
Common Stock 500 Indirect By spouse IRA
Footnotes
  1. The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $118.60 to $118.76. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
  2. Securities held in a charitable foundation that was established for the sole purpose of making charitable contributions. The directors of the foundation are the Reporting Person, his spouse and their adult children. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
  3. Includes shares related to dividends on shares in the Reporting Person's Deferred Compensation Plan account.